Back
Syndax Pharmaceuticals Vs. Madrigal Pharmaceuticals Industry Stock Comparison
Sell
48
SNDX
Syndax Pharmaceuticals
Last Price:
20.30
Seasonality Move:
8.3%
Buy
54
MDGL
Madrigal Pharmaceuticals
Last Price:
220.06
Seasonality Move:
-8.39%
Sell
48
Syndax Pharmaceuticals (SNDX)
is a Sell
Is Syndax Pharmaceuticals a Buy, Sell or Hold?
- The current Syndax Pharmaceuticals [SNDX] share price is $20.29. The Score for SNDX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- SNDX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
Madrigal Pharmaceuticals (MDGL)
is a Buy
Is Madrigal Pharmaceuticals a Buy, Sell or Hold?
- The current Madrigal Pharmaceuticals [MDGL] share price is $220.06. The Score for MDGL is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- MDGL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SNDX Stock Price Chart
What is Syndax Pharmaceuticals's stock price today?
-
The Syndax Pharmaceuticals share price today is $20.29
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SNDX is experiencing selling pressure, which indicates risk of future bearish movement.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals's stock price today?
-
The Madrigal Pharmaceuticals share price today is $220.06
The current trend is relatively stagnant and MDGL is experiencing buying pressure, which is a positive indicator for future bullish movement.
SNDX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.22 | Sell |
| Relative Strength Index (14 RSI): | 39.21 | Sell |
| Chaikin Money Flow: | -882942 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.71 - 22.09) | Sell |
| Bollinger Bands (100): | (21.01 - 23.19) | Sell |
MDGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.21 | Sell |
| Relative Strength Index (14 RSI): | 50.69 | Buy |
| Chaikin Money Flow: | 130228 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (203.16 - 225.52) | Buy |
| Bollinger Bands (100): | (211.12 - 251.34) | Sell |
SNDX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.49 | Sell |
| 20-day SMA: | 21.51 | Sell |
| 50-day SMA: | 22.17 | Sell |
| 200-day SMA: | 19.1 | Buy |
| 8-day EMA: | 21.31 | Sell |
| 20-day EMA: | 21.58 | Sell |
| 50-day EMA: | 21.81 | Sell |
| 200-day EMA: | 20.64 | Sell |
MDGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 211.46 | Buy |
| 20-day SMA: | 211.56 | Buy |
| 50-day SMA: | 234.2 | Sell |
| 200-day SMA: | 201.75 | Buy |
| 8-day EMA: | 214.56 | Buy |
| 20-day EMA: | 216.55 | Buy |
| 50-day EMA: | 224.38 | Sell |
| 200-day EMA: | 215.91 | Buy |
Syndax Pharmaceuticals Earnings Growth & SNDX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.03 per share, a decrease this year of $0.65 per share, and an increase next year of $0.75 per share.
Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $2.35 per share, an increase next quarter of $1.27 per share, a decrease this year of $9.09 per share, and an increase next year of $10.64 per share.
Syndax Pharmaceuticals Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Madrigal Pharmaceuticals Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||